N. Wong

Cardiology and Cardiovascular Medicine · Circulation · 2001–2019

A researcher in the Science corpus: 17 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom N. Wong trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. F. Turnbull
  2. S. Kaptoge
  3. Daniel Levy

Who trusts N. Wong overall

  1. T. Ivanova
  2. R. Eckel

Papers from N. Wong's perspective

Ordered by how strongly the researchers N. Wong trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)
  2. Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention (The Lancet)
  3. Predicting the Thirty-year Risk of Cardiovascular Disease: The Framingham Heart Study (Circulation)
  4. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. (Health Psychology)
  5. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. (New England Journal of Medicine)
  6. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. (Circulation)
  7. Designing Health Care for the Most Common Chronic Condition—Multimorbidity (Journal of the American Medical Association (JAMA))
  8. Clinical Prediction Models—a Practical Approach to Development, Validation and Updating
  9. Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
  10. Rosuvastatin in older patients with systolic heart failure. (Current Atherosclerosis Reports)

Their papers